Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea

OBJECTIVE: To evaluate the impact of solriamfetol, a dopamine and norepinephrine reuptake inhibitor, on on‐the‐road driving in participants with excessive daytime sleepiness (EDS) associated with obstructive sleep apnoea (OSA). METHODS: Eligible participants were aged 21–75 years with OSA and EDS (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinckenbosch, Frederick, Asin, Jerryll, de Vries, Nicolaas, Vonk, Patty E., Donjacour, Claire E. H. M., Lammers, Gert Jan, Overeem, Sebastiaan, Janssen, Hennie, Wang, Grace, Chen, Dan, Carter, Lawrence P., Zhou, Kefei, Vermeeren, Annemiek, Ramaekers, Johannes G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788130/
https://www.ncbi.nlm.nih.gov/pubmed/35633275
http://dx.doi.org/10.1002/hup.2845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788130/
https://www.ncbi.nlm.nih.gov/pubmed/35633275
http://dx.doi.org/10.1002/hup.2845

Ejemplares similares